Prof. Dr. med. Christian Seidl

• Bender N, Seidl C, Weichert W, Breddin HK. Evaluation of the Biological Effects of Low-Molecular-Weight-Heparins. Haemostasis 1988; 18 (Suppl. 3): 23-32.
• Seidl C, Saraiya C, Osterweil Z, Fu YP, Lee JS. Genetic complexity of regulatory mutant defective for HLA Class II gene expression. J Immunol 1992; 148: 1576-1584.
• Gärtner H, Seidl C, Luckenbach C, Seifried E ,Ritter H. Genetic analysis of a sarcoma accidentally transplanted from a patient to a  surgeon. N Engl J Med 1997;  335: 1494-1496.
• Huang CH, Chen Y, Reid ME, Seidl C. Rhnull disease: the amorph type results from a novel double mutation in RhCe gene on D-negative background. Blood. 1998 Jul 15;92(2):664-71.
• Seidl C, Siehl J, Ganser A, Hofmann W-K, Fischer M, Kirchmaier CM, Hoelzer D, Seifried E. Platelet glycoprotein expression in patients with myelodysplastic syndrome. Thromb Res 2000; 100: 27-34
• Seidl C, Körbitzer J, Badenhoop K, Seifried E, Hoelzer D, Zanelli E, Kaltwasser JP. Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among rheumatoid arthritis patients carrying the HLA-DQ3-DR4 and HLA-DQ5-DR1 haplotypes. Hum Immunol 2001; 62: 523-529.
• Becker S, Tonn T, Füssel T, Uhrberg M, Seifried E, Seidl C. Assessment of Killer Cell Immunoglobulin-like Receptor (KIR) expression and corresponding HLA-class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA-class I ligands. Hum Immunol 2003; 64(2): 183-193.
• Koehl U, Beck O, Esser R, Seifried E, Klingebiel T, Schwabe D, Seidl C. Quantitative analysis of chimerism after allogeneic cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience. Leukemia 2003; 17(1): 232-236.
• Richter R, Süsal C, Köhler S, Qidan S, Schödel A, Holschuh L, Brzoska M, Asbe-Vollkopf A, Büttner S, Betz C, Herrmann E, Gauer S, Seifried E, Geiger H, Seidl C, Hauser IA. Pre-transplant HLA Antibodies Detected by Single Antigen Bead Assay are a Risk Factor for Long-Term Kidney Graft Loss Even in the Absence of Donor Specific Antibodies. Transpl Int. 2016 Sep;29(9):988-98.
• Becker PS, Suck G, Nowakowska P, Ullrich E, Seifried E, Bader P, Tonn T, Seidl C. Selection and expansion of natural killer cells for NK cell-based immunotherapy. Cancer Immunol Immunother. 2016 Apr;65(4):477-84.
• Arnold ML, Bach C, Heinemann FM, Horn PA, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Schaub S, Hönger G, Fischer GF, Mytilineos J, Hallensleben M, Hitzler WE, Seidl C, Spriewald BM.  Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival. Int J Immunogenet. 2018 Jun;45(3):95-101.
• Ziemann M, Suwelack B, Banas B, Budde K, Einecke G, Hauser I, Heinemann FM, Kauke T, Kelsch R, Koch M, Lachmann N, Reuter S, Seidl C, Sester U, Zecher D. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients.  HLA. 2022 Jul;100(1):3-17. 

Ausgewählte Bücher/Buchbeiträge

• Seidl C, Seifried E.  Chapter 11. Quality management and inspection in blood transfusion medicine. in.: Blood, Tissue and Cells from Human Origin (Ed. Follea G), ISBN 9789082031003, published by the European Blood Alliance (EBA), 2013
• Seidl C, Seifried E. Immunogenetics: Clinical and diagnostic aspects of the human leukocyte antigen (HLA) system. In: Lothar Thomas (Ed.) Laboratory Pathology. Indications and Assessment of Laboratory Results for Clinical Diagnostics. 1st Englisch Edition (2016), p1532-1537
• Seidl C, Seifried E (Editoren). European Blood Inspection Project (EuBIS)  Manual and Inspection/audit training Guide on common criteria and standards for the inspection of blood establishments. Manual and Guide published under the Public Health Programme of the Europen Commission. Revised Edition 1.0.1, September 2016.  Addendum.: Chinese Translation by the Beijing Red Cross Blood Center and the Management Committee of the Chinese Society of Blood Transfusion. Published 2022